NBIE - ETF AI Analysis
Top Page
Neuberger International Core Equity ETF (NBIE)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, indicating positive momentum.
Leading Top Holdings
Several of the largest positions, including ASML and BHP, have shown strong performance, helping support the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries such as Japan, the U.S., the UK, and several European and Asia-Pacific markets, reducing reliance on any single economy.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially high but is also not among the very cheapest ETFs, slightly reducing net returns over time.
Heavy Exposure to a Few Countries
A significant portion of assets is concentrated in markets like Japan, the U.S., and the UK, which can increase sensitivity to economic or political issues in those regions.
Sector Tilt Toward Financials
With a sizable allocation to financial companies, the ETF may be more affected by changes in interest rates and banking sector conditions.
NBIE vs. SPDR S&P 500 ETF (SPY)
AUM252.05M
RegionDeveloped Markets
Expense Ratio0.29%
Beta0.67
IssuerNeuberger Berman
Inception DateMar 06, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,716
30 Day Avg. Volume27,742
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.54Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering240
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NBIE Summary
NBIE, the Neuberger International Core Equity ETF, is an actively managed fund that invests in a wide mix of companies from developed markets outside the U.S., with some U.S. exposure as well. It doesn’t track a single index, but instead follows a broad international stock market theme, focusing mainly on large and mid-sized companies across many sectors. Well-known holdings include ASML Holding and Novartis. Investors might consider NBIE for global diversification and long-term growth potential. However, its value can go up and down with global stock markets and is affected by currency swings and international political events.
How much will it cost me?This ETF has an expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 you invest. That’s a bit higher than the average index ETF because this fund is actively managed, with a research team selecting international stocks rather than just tracking a simple market index.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. experience steady economic growth, which would support its broad mix of financial, industrial, health care, and technology companies, and if global demand for areas like semiconductors, energy, and materials remains strong for holdings such as ASML, Shell, and BHP. On the other hand, slower growth or recessions in Europe and other developed regions, currency swings versus the U.S. dollar, tighter regulations on banks, energy, or health care, or geopolitical tensions affecting international trade could weigh on the fund’s performance.
NBIE Top 10 Holdings
NBIE leans heavily on non-U.S. blue chips, with Dutch chip-equipment giant ASML acting as a key engine: it’s had a strong run this year, even if momentum has cooled lately. Industrial player ABB is another bright spot, rising steadily and giving the fund a lift. On the flip side, Shell has been losing steam, recently dragging on returns despite its solid fundamentals. Health care names like Novartis and Roche are more steady than spectacular, while European banks such as BBVA and NatWest are quietly climbing, underscoring the ETF’s developed-markets ex-U.S. tilt with a notable financials and industrials flavor.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.73% | $9.33M | €572.60B | 143.26% | 76 Outperform | |
| Novartis AG | 2.17% | $5.43M | CHF230.61B | 32.06% | 80 Outperform | |
| Roche Holding AG | 2.05% | $5.12M | $361.51B | 51.16% | 73 Outperform | |
| BHP Group Ltd | 2.04% | $5.10M | AU$319.93B | 76.56% | 68 Neutral | |
| Shell (UK) | 1.68% | $4.21M | £181.34B | 24.71% | 73 Outperform | |
| ABB Ltd | 1.63% | $4.08M | kr1.72T | 55.38% | 78 Outperform | |
| UBS Group AG | 1.61% | $4.03M | $162.48B | 39.07% | 73 Outperform | |
| Intesa Sanpaolo SpA | 1.47% | $3.67M | €120.49B | 28.79% | 76 Outperform | |
| GlaxoSmithKline | 1.36% | $3.39M | £78.56B | 37.29% | 77 Outperform | |
| Enel S.p.A. | 1.36% | $3.39M | €102.01B | 27.23% | 67 Neutral |
NBIE Technical Analysis
Positive
―
Price Trends
26.53
Positive
25.94
Positive
Market Momentum
0.35
Negative
66.25
Neutral
85.48
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NBIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.96, equal to the 50-day MA of 26.53, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.35 indicates Negative momentum. The RSI at 66.25 is Neutral, neither overbought nor oversold. The STOCH value of 85.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NBIE.
NBIE Peer Comparison
Comparison Results
Performance Comparison
NBIE
Neuberger International Core Equity ETF
27.63
2.63
10.52%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
DXIV
Dimensional International Vector Equity ETF
―
―
―
RFDI
First Trust Riverfront Dynamic Developed International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents